PRKAA1 and fragile X-associated tremor/ataxia syndrome: The results show that the AMPK activity and ATP steady state levels are significantly elevated in both FXTAS and non-FXTAS subgroups compared with controls; while the levels of TORC1 activity and ROS levels are consistently reduced in both carrier subgroups compared with controls.